- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in Dr Reddy s Laboratories
Sputnik V meets primary endpoint of safety in phase 2 clinical trial in India
Sputnik V meets primary endpoint of safety in phase 2 clinical trial in India
Read More
NSE Lists ADRs At NSE IFSC In GIFT City
Participants holding depository accounts with either of the international central securities depository (Euroclear Bank, Clearstream) or Depository Trust Company (DTC) will be able to transact on these ADRs.
Read MoreSputnik V from Russia arrives in India for clinal trials
Sputnik V from Russia arrives in India for clinal trials
Read MoreDr Reddy's Lab submits revised protocol to DCGI to conduct phase 2,3 clinical trials of Russian COVID-19 vaccine
Dr Reddy's Lab submits revised protocol to DCGI to conduct phase 2,3 clinical trials of Russian COVID-19 vaccine
Read More
Dr Reddy's Joins Science Based Targets Initiative (Sbti), Sets 2030 GHG Emission Targets
The company has committed to reducing its scope one and two greenhouse gas (GHG) emissions by 55 per cent by 2030 from an FY 2017-18 base year
Read More
India Trials For Russia's 'Sputnik-V' Vaccine Could Start In Next Few Weeks - Executive
India, which has a population of more than 1.3 billion, is the world's second worst affected country by COVID-19 behind the United States.
Read More
Equity Indices Trade Higher, Pharma Stocks Rally
BSE S&P Sensex was up by 136 points or 0.35 per cent at 39,115 while the Nifty 50 moved up by 56 points or 0.48 per cent at 11,576.
Read MoreDr Reddy's, RDIF to supply 100 million doses of Sputnik V vaccine to India
Dr Reddy's, RDIF to supply 100 million doses of Sputnik V vaccine to India
Read More
Dr Reddy's Launches Redyx (Remdesivir) In India For COVID-19 Treatment
Remdesivir is approved by Drug Controller General of India (DCGI) for restricted emergency use in India for the treatment of Covid-19 patients hospitalised with severe symptoms.
Read More
Dr Reddy's Laboratories Launches COVID-19 Treatment Drug In India
Dr Reddy's said Avigan has been approved by the Drugs Controller General of India (DCGI) for the treatment of patients with mild to moderate COVID-19.
Read MoreDr Reddy's launches Avigan (Favipiravir) for COVID-19 treatment
Dr Reddy's launches Avigan (Favipiravir) for COVID-19 treatment
Read MoreDr Reddy's net profit falls 13 pc to Rs 579 cr in June quarter
Dr Reddy's net profit falls 13 pc to Rs 579 cr in June quarter
Read MoreDr Reddy's Labs In Licensing Pact With Gilead Sciences For Remdesivir
Gilead Sciences has signed similar non-exclusive voluntary licensing agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan and Zydus Cadila.
Read More